ROLE SUMMARY

Patient preferences have an increasingly important role in healthcare decision making. Health authorities and HTA bodies are encouraging companies include patients in drug development and to provide evidence of the patient perspective on the benefit, risk, and value of their products. Evidence of preference heterogeneity can be used to encourage and guide shared clinical decision making. The Patient Preference Evidence Generation is responsible developing and using the patient preference capabilities across the enterprise to support patient-centered decision making related to Pfizer IM/I&I assets among external stakeholders including Health Authorities, Health Technology Assessors, healthcare providers, and policy makers, among others. The PPEG for IM/I&I will oversee patient preference evidence generation activities and ensure excellence in the development and use of patient preference information to support external decision making related to pipeline and inline IM/I&I products and programs.

ROLE RESPONSIBILITIES

• Provide expert support and leadership to IM and I&I asset teams in the design and execution of fit-for purpose preference studies (including patient preference studies (PPS),HCP preference studies and other stakeholder preference studies).
• Champion inclusion of the preference data in evidence generation activities across the life cycle of all IM and I&I assets.
• Lead the development of preference data as evidence to demonstrate the value of Pfizer IM and I&I products to external stakeholders (Health Authorities, HTA Bodies, Payers, Healthcare Providers, etc.).
• Collaborate with IM and I&I evidence generation planning teams to include preference studies in Integrated Evidence Planning.
• Lead preference data generation activities to support categories of IM and I&I assets (including, for example assessments of unmet need, adverse event indices, and drug product formulations).
• Develop and implement innovative uses of omnichannel dissemination vehicles for increasing the impact of Pfizer-sponsored preference studies.
• Participate actively in preference study governance, educational, and information-sharing activities through leadership in the PPS Technical Advisory Committee, the PPS Community of Practice and internal and external presentations.
• Participate actively in interactions with regulators, HTA bodies and other external decision makers related to IM/I&I preference studies.
• In conjunction with other members of the Patient Preference Integration team, track changes in external best-practice guidance (e.g., ICH, IMI/IHI, ISPOR and other guidances) and implement recommendations and guidelines in the conduct of patient preference studies as appropriate.
• In conjunction with other members of the Patient Centered Research and Partnerships team, support interactions with patient groups and include patients as partners in research.
• Develop tools, templates, job aids, slide presentations, and other materials as necessary to educate colleagues on good PPS research practices, to increase efficiency in project execution, and to assist colleagues in the conduct of the PPS wherever possible.
• Use AI and LLM tools to increase efficiency in preference evidence generation while maintaining superior quality of Pfizer preference studies.
• Develop and implement metrics to track progress and impact of preference evidence generation activities and initiatives.
• Participate regularly in research with intent to publish.

BASIC QUALIFICATIONS

• Advanced degree, including MS, MA, PhD or equivalent qualifications in a field related to quantitative preference elicitation including, but not limited to, economics, statistics, decision science, survey research methods, and epidemiology.
• At least 10 years' experience hands-on expertise with a BS/BA, 8 years' experience with an MBA/MS, 6 years' experience with a PhD.
• In-depth knowledge of Preference Elicitation methods including, but not limited to discrete choice experiments, best-worst scaling, threshold techniques, swing weighting, and direct elicitation
• A proven publication record
• Knowledge of pharmaceutical clinical, commercial, regulatory, and competitive issues as well as relevant Health Authority guidelines.
• Ability to establish a vision and obtain buy-in and endorsement from cross-functional parties across the lifecycle
• Strong situational leadership skills & the ability to lead through influence in cross-functional & highly matrixed teams
• Proven ability to lead teams, build coalitions and develop strong partnerships across disciplines and geographies in a matrix environment to optimize the function's performance and contribution.
• Excellent customer-service orientation and ability to think innovatively to develop solutions
• Proven ability to devise and manage metrics/scorecards to measure effectiveness and productivity; strong analytic skills, including the ability to build qualitative and quantitative arguments.
• Able to act with limited day-to-day oversight once a vision and framework for objectives is established as well as cross-functionally to achieve program goals
• Demonstrated strong work ethic, and proven track record of delivering high quality within timelines.
• Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

PREFERRED QUALIFICATIONS

• Experience of qualitative or mixed methodology in additional to quantitative methodology preferred.
• Publication of preference studies in diseases and indications related to IM and I&I preferred.
• Leadership in a related scientific field, e.g., in professional societies, government, international bodies, etc.
• Excellence in speaking/communicating publicly as evidenced by presentations at congresses, participation on committees/working groups, etc.
• Global healthcare experience working across different markets; experience working in US healthcare and with US Patient Advocacy groups or Patient Involvement and Engagement initiatives highly preferred
• Demonstration of a wide network of peers in relevant disciplines (e.g., co-authors and participation on professional societies, technical working groups, committees, etc.)

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS

Travel of 5-10%, depending on budgets, organizational needs, and any other relevant restrictions

Work Location Assignment: Hybrid

The annual base salary for this position ranges from $169,700.00 to $282,900.00. In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site - U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.

Medical

#LI-PFE